Ian A. Sharpe, PhD

School of Biomedical Sciences University of Queensland, Saint Lucia, Queensland, Australia 
"Ian Sharpe"
Mean distance: 15.93 (cluster 31)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Paczkowski FA, Sharpe IA, Dutertre S, et al. (2007) chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model. The Journal of Biological Chemistry. 282: 17837-44
Nilsson KP, Lovelace ES, Caesar CE, et al. (2005) Solution structure of chi-conopeptide MrIA, a modulator of the human norepinephrine transporter. Biopolymers. 80: 815-23
Sharpe IA, Palant E, Schroeder CI, et al. (2003) Inhibition of the norepinephrine transporter by the venom peptide chi-MrIA. Site of action, Na+ dependence, and structure-activity relationship. The Journal of Biological Chemistry. 278: 40317-23
Sharpe IA, Thomas L, Loughnan M, et al. (2003) Allosteric alpha 1-adrenoreceptor antagonism by the conopeptide rho-TIA. The Journal of Biological Chemistry. 278: 34451-7
Sharpe IA, Gehrmann J, Loughnan ML, et al. (2001) Two new classes of conopeptides inhibit the alpha1-adrenoceptor and noradrenaline transporter. Nature Neuroscience. 4: 902-7
Lewis RJ, Nielsen KJ, Craik DJ, et al. (2000) Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes. The Journal of Biological Chemistry. 275: 35335-44
Bowles MR, Mulhern TD, Gordon RB, et al. (1997) Bound Tris confounds the identification of binding site residues in a paraquat single chain antibody. Journal of Biochemistry. 122: 101-8
Bryan-Lluka LJ, Seers H, Sharpe I. (1996) Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats Naunyn-Schmiedeberg's Archives of Pharmacology. 353: 536-544
See more...